# DAPSONE
> **ANDA210178** · Abbreviated New Drug Application (Generic) · Sponsor: COSETTE · Approved 2022-03-31
## Drug
- **FDA Application Number:** ANDA210178
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPSONE
- **Generic name:** DAPSONE
- **Active ingredients:** DAPSONE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** COSETTE
- **Manufacturer:** Cosette Pharmaceuticals, Inc.
- **First approval:** 2022-03-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210178)
---
*AI Analytics · CC0 1.0*